190 related articles for article (PubMed ID: 6419747)
1. Alterations in rat serum lipids and apolipoproteins following clofibrate treatment.
Dashti N; Ontko JA
Atherosclerosis; 1983 Dec; 49(3):255-66. PubMed ID: 6419747
[TBL] [Abstract][Full Text] [Related]
2. Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat.
Groener JE; van Gent T; van Tol A
Biochim Biophys Acta; 1989 Mar; 1002(1):93-100. PubMed ID: 2493808
[TBL] [Abstract][Full Text] [Related]
3. Effects of castration and testosterone administration on serum lipoproteins and their apoproteins in male spontaneously hypertensive rat.
Takeuchi N; Go S; Murase M; Nomura Y; Takase H; Uchida K
Endocrinology; 1986 May; 118(5):1787-94. PubMed ID: 3084207
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of apolipoproteins B, C-I, C-II, C-III, E and lipids in serum and serum lipoproteins of normal subjects during alimentary lipaemia.
Annuzzi G; Holmquist L; Carlson LA
Scand J Clin Lab Invest; 1989 Feb; 49(1):73-81. PubMed ID: 2727620
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
[TBL] [Abstract][Full Text] [Related]
6. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.
Samuelsson O; Attman PO; Knight-Gibson C; Kron B; Larsson R; Mulec H; Weiss L; Alaupovic P
Nephron; 1997; 75(3):286-94. PubMed ID: 9069450
[TBL] [Abstract][Full Text] [Related]
7. A novel compound that elevates high density lipoprotein and activates the peroxisome proliferator activated receptor.
Bisgaier CL; Essenburg AD; Barnett BC; Auerbach BJ; Haubenwallner S; Leff T; White AD; Creger P; Pape ME; Rea TJ; Newton RS
J Lipid Res; 1998 Jan; 39(1):17-30. PubMed ID: 9469582
[TBL] [Abstract][Full Text] [Related]
8. Serum lipoprotein and apoprotein concentrations in 4-(4-chlorophenyl)-2-hydroxytetronic acid and clofibrate-treated cholesterol and cholic acid-fed rats.
Kamanna VS; Newman HA; Patel ST; Tehim AK; Witiak DT; Feller DR
Lipids; 1989 Jan; 24(1):25-32. PubMed ID: 2747427
[TBL] [Abstract][Full Text] [Related]
9. Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics.
Prager R; Schernthaner G; Kostner GM; Mühlhauser I; Zechner R; Dorda W
Atherosclerosis; 1982 Jun; 43(2-3):321-7. PubMed ID: 6810904
[TBL] [Abstract][Full Text] [Related]
10. Modulation of lipoprotein production in Hep G2 cells by fenofibrate and clofibrate.
Hahn SE; Goldberg DM
Biochem Pharmacol; 1992 Feb; 43(3):625-33. PubMed ID: 1311585
[TBL] [Abstract][Full Text] [Related]
11. Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: I. Chow-fed animals.
O'Brien M; Patel ST; Mukhopadhyay A; Newman HA; Feller DR; Kokrady SS; Witiak DT; Lanese RR; Rice JC
Lipids; 1981 Dec; 16(12):903-11. PubMed ID: 7329211
[TBL] [Abstract][Full Text] [Related]
12. Serum apolipoprotein A-I, A-II and B levels and their discriminative values in relatives of patients with coronary artery disease.
Kukita H; Hiwada K; Kokubu T
Atherosclerosis; 1984; 51(2-3):261-7. PubMed ID: 6430307
[TBL] [Abstract][Full Text] [Related]
13. Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid esters.
Vessby B; Lithell H; Hellsing K; Ostlund-Lindqvist AM; Gustafsson IB; Boberg J; Ledermann H
Atherosclerosis; 1980 Oct; 37(2):257-69. PubMed ID: 7000090
[No Abstract] [Full Text] [Related]
14. Abstinence-induced changes in plasma apolipoprotein levels of alcoholics.
Barboriak JJ; Alaupovic P; Cushman P
Drug Alcohol Depend; 1981 Dec; 8(4):337-43. PubMed ID: 6802625
[TBL] [Abstract][Full Text] [Related]
15. Dietary-fish effects on serum lipids and apolipoproteins, a controlled study.
van Houwelingen R; Zevenbergen H; Groot P; Kester A; Hornstra G
Am J Clin Nutr; 1990 Mar; 51(3):393-8. PubMed ID: 2309645
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein and lipid abnormalities in uremic children on hemodialysis.
Ohta T; Matsuda I
Clin Chim Acta; 1985 Apr; 147(2):145-54. PubMed ID: 3921292
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein abnormalities in survivors of cerebral infarction with a special reference to apolipoproteins and triglyceride-rich lipoproteins.
Matsuda M; Miyahara T; Murai A; Fujimoto N; Kameyama M
Atherosclerosis; 1987 Nov; 68(1-2):131-6. PubMed ID: 3689476
[TBL] [Abstract][Full Text] [Related]
18. Effect of feeding diets of varying fatty acid composition on apolipoprotein expression in newborn swine.
Wang H; Hunter F; Black DD
Am J Physiol; 1998 Oct; 275(4):G645-51. PubMed ID: 9756492
[TBL] [Abstract][Full Text] [Related]
19. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
Murdoch SJ; Breckenridge WC
Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
[TBL] [Abstract][Full Text] [Related]
20. Reduced LDL- and increased HDL-apoproteins in patients with hypercholesterolaemia under treatment with bezafibrate.
Mordasini R; Riesen W; Oster P; Keller M; Middelhoff G; Lang PD
Atherosclerosis; 1981 Oct; 40(2):153-8. PubMed ID: 6796096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
